French drugmaker Sanofi (SASY.PA), opens new tab will invest 1.3 billion euros ($1.40 billion) in a new insulin production facility at its existing site in Frankfurt, where it makes insulin brand Lantus, the company said on Thursday. The investment will pave the way for the construction of a 36,000-square-metre facility that will replace Sanofi's current insulin production plant in Frankfurt's Hoechst district by 2029. Source: Reuters 1/8/2024